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A B S T R A C T
Several Finnish dairy herds have suffered from outbreaks of interdigital phlegmon (IP). In these new types of
outbreaks, morbidity was high and clinical signs severe, resulting in substantial economic losses for affected
farms. In our study, we visited 18 free stall dairy herds experiencing an outbreak of IP and 3 control herds
without a similar outbreak. From a total of 203 sampled cows, 60 suffered from acute stage IP. We demonstrated
that acute phase response of bovine IP was evident and therefore an appropriate analgesic should be adminis-
tered in the treatment of affected animals. The response was most apparent in herds with high morbidity in IP
and with a bacterial infection comprising Fusobacterium necrophorum and Dichelobacter nodosus, indicating that
combination of these two bacterial species affect the severity of the disease.
1. Introduction
Several Finnish dairy herds have recently suffered from outbreaks of
interdigital phlegmon (IP). The affected herds have been naïve – with
no previous history of IP. It is also evident that an apparent trauma in
the interdigital cleft was not detected prior the cases of IP. In these
outbreaks, morbidity of IP has usually been high and clinical signs se-
vere, resulting in sizeable economic losses for affected herds [1]. Prior
to these new type outbreaks, infectious hoof diseases were quite rare in
Finland.
Most countries with a modern dairy industry have experience with
infectious hoof diseases, of which digital dermatitis (DD) is currently
considered the most problematic [2,3]. However, cases of IP also ap-
pear regularly [4,5] and there are a few earlier reports of outbreaks of
IP [6,7]. Typically, the clinical signs of IP are lameness, a symmetric
swelling of the interdigital area and the bulbs of the heels, and a fetid
odor. A fissure with swollen protruding edges can appear along the
interdigital cleft. In severe cases, systemic signs, including fever, re-
cumbency or anorexia appear [8,9]. IP reduces milk yield [10] and can
lead to early culling of affected cows [11].
Fusobacterium necrophorum is considered to be a major pathogen of
IP [12–14], although in the disease process several other bacteria, in-
cluding Dichelobacter nodosus, Porphyromonas levii, Prevotella melanino-
genica, Treponema species and Trueperella pyogenes play a probable role
[8,13,15–17]. In our recent study, we frequently detected both F. ne-
crophorum and D. nodosus in IP, and D. nodosus was associated with
higher morbidity [14].
Several review articles describe an acute phase response (APR) as an
early systemic, non-specific response of the host to infection, in-
flammation or trauma, with the purpose of restoring normal body
functions [18–22]. APR includes multiple metabolic, endocrinal and
hematological changes, and it is often expressed by clinical signs –
fever, anorexia, apathy and pain [18]. APR is induced by cytokines
acting as messengers between the local sites of injury and leads to the
hepatic synthesis of acute phase proteins (APP) [19–21]. APPs are likely
to participate directly in the protection of the host [20]. APPs are a
measurable element of APR, and are classified as positive or negative,
and according to the magnitude of their increase as minor, moderate or
major [19–21].
Reports of APPs in hoof diseases and lameness have been published
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previously [23–25]. These studies mainly include detection of two
major APPs in cattle: serum amyloid A (SAA) and haptoglobin (Hp).
Also, some studies of albumin (Alb), a negative APP, exist [26]. How-
ever, studies that include cases of infectious hoof diseases and APR are
scant [27–29]. Thus, we investigated the association between clinical
signs and APR in IP, to evaluate the degree of inflammation in naturally
occurring IP. Furthermore, we investigated the characteristics of these
new type outbreaks of IP and tested our hypothesis that presence of D.
nodosus alongside F. necrophorum affects the severity of IP.
2. Materials and methods
We carried out a research project on infectious hoof diseases in
Finland in 2012–2015. As a part of the project we made a cross-sec-
tional study, visiting several dairy herds affected by outbreaks of IP and
control herds.
2.1. Study herds
The study herds, selection of sampled animals, and sampling are
described in detail in our previous study [14]. One outbreak herd was
excluded from the current study due to missing data and dissimilar barn
construction; manure pack flooring in a non-insulated free stall. Only
cows with complete blood sample analysis were included in the study.
We collected samples from 21 commercial free stall dairy herds.
Eighteen herds suffered from an outbreak of IP (IP herd) and three
herds had been free of IP for at least a decade. The criteria for visiting
an outbreak of IP herd were; at least three cows affected in one week,
and no previous cases of IP in the herd for at least ten years. The out-
break herds were further divided into two categories, herds with high
morbidity in the first two months of the outbreak (morbidity ≥50 %)
and herds with moderate morbidity (9–33%).
The study herds were located in three large provinces in Finland:
western (11 farms), eastern (7) and southern (3). The average herd size
was 76 lactating cows (range 37–140, median 62) and the average milk
yield of the herds was 9207 kg (8,000–10,914 kg, median 9219). All
free stalls were constructed or extended at most seven years before the
farm visit. Cows were milked twice a day in a milking parlor in 4 herds,
whereas 16 herds were milked using an automatic milking system, and
one herd had both. The alleys had slatted concrete floors in 10 barns,
slatted floors with rubber in 3, solid with rubber in 7 and in 1 barn solid
concrete. During summer, 4 herds had access to pasture, 2 herds access
to an outdoors pen and of these 6 herds 2 had access outdoors during
winter. A total or partial mixed ration was fed in 13 herds whereas in 8
herds concentrates and silage were fed separately.
During the farm visits we collected background data on barn con-
struction and herd management. An additional checkup was made a
year after the visit by phone interview.
2.2. Selection and clinical inspection of the animals
The cows were selected for sampling on the grounds of lameness,
prolonged lying-time, or a trouble report from an automatic milking
system. All feet were carefully inspected in a trimming chute. Primarily,
samples were collected from cows that had IP. If several feet of a cow
were affected, the foot with the most severe lesion in the interdigital
cleft was selected for sampling. The bacteriological samples were taken
from the lesion site. The IP lesions were further classified as acute in-
fection (hereafter termed acute IP) or a healing stage of IP (healing IP).
The diagnosis of IP was made according to Gupta et al. [8]: acute IP was
diagnosed if the distal foot near the claws was swollen symmetrically
with or without a fissure detected in the interdigital cleft, and the
healing IP was defined by proliferation tissue or scar formation being
apparent in the affected region. Some IP cows had also other hoof
diseases, like heel horn erosion (HHE), DD or white line disease. If IP
was considered the main reason for lameness the cow was sampled as IP
cow.
Some samples were taken from cows that suffered from DD
(n= 14). DD diagnosis was made according to Döpfer et al. [30]. All
DD lesions represented either stage M1, M2 or M3 and were less than
3 cm in diameter. If observed, we also sampled cows with other hoof
diseases, including interdigital dermatitis (ID), sole ulcer, or white line
abscess (hereafter termed Other, n= 34).
The study cows were checked for lameness and classified into lame
or non-lame categories (0/1) while standing or walking to and from the
trimming chute. Cows were scored according to Sprecher et al. [31] so
that the category of non-lame cows included cows 1–2 and lame cows
3–5 on this scale. Their body temperature was measured and previous
antimicrobial treatments from one month before the herd visit were
recorded. A separate form was used to enter all data relating to the
cows.
The control cows in both herd types, IP herds and IP-free herds,
were selected from non-lame, non-pyretic (T≤ 39.2 °C), otherwise
clinically healthy cows. Their feet were lifted in a trimming chute, and
those with no signs of IP, DD, ID, sole ulcer or white line disease were
selected as control cows. Occasionally on some farms, it was impossible
to find healthy control cows without any hoof diseases. Therefore, a
mild HHE i.e. superficial loss of heel horn as categorized 0 on a scale of
0/1 by Manske et al. [32], was accepted on some control cows. In
outbreak herds, the control cows are later referred to as control cows
(IP herd), and in herds with no outbreak of IP, as control cows (IP-free
herd). All the diagnoses were made by one of two experienced veter-
inarians and were based on clinical signs only. All feet were photo-
graphed in a trimming chute and diagnoses were standardized between
the two veterinarians by studying the photographs together.
In this study, a total of 203 cows were sampled: 117 (57.6 %) were
Ayrshire and 86 (42.4 %) Holstein. Moreover, 95 (46.8 %) were heifers
or first parity cows, 46 (22.7 %) second parity and 57 (28.1 %) third or
more parity cows. The lactation stage data for sampled cows were: 71
(35.0 %) early lactation (1–120 DIM), 84 (41.4 %) late lactation
(121–305 DIM) and 43 (21.2 %) either over 305 DIM, dry cows or
heifers. All study heifers (n=8) were in late pregnancy, 0–2 months
prior to calving. The information on parity and lactation stage was
missing for 5 (2.5 %) cows.
2.3. Blood samples and analysis of acute phase proteins
We collected the blood samples (9 ml Z Serum Clot Activator,
Vacuette, Austria) from jugular or mammary veins for subsequent
analysis of APPs. The whole blood samples were centrifuged at
3500 rpm for 15min, serum was placed in a 2ml tube (Sarstedt,
Germany) and frozen at – 20 °C within 24 h of sampling.
We analyzed SAA, Hp and Alb. Serum SAA concentration was
measured with a commercially available solid phase sandwich ELISA kit
(Phase TM Range Multispecies SAA ELISA kit, Tridelta Development
Ltd., Ireland) according to the manufacturer’s instructions for bovines.
The lower detection limit was 9.4 μg/ml and all samples with
concentrations< 9.4 μg/ml were set to 9.4 μg/ml. Serum Hp con-
centration was determined using a hemoglobin-haptoglobin binding
assay (Phase TM Range Haptoglobin kit, Tridelta Development Ltd.,
Ireland). Spectrophotometric methods were used for the determination
of Alb [33] and were performed with an automatic chemistry analyzer
(KONE Pro, Thermo Fisher Scientific, Finland).
2.4. Bacteriological sampling and analysis of hoof samples
The sampling methods, and the results of the bacteriological ana-
lyses are described in detail in Kontturi et al. [14]. Briefly, the sampling
was performed in a trimming chute and the affected foot was lifted and
the two claws were spread with an extensor. The hoof region was
cleaned carefully with a hose, rinsed with saline, and dried with gauze.
The cytobrush samples were taken from the inflamed region – samples
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from IP cows were collected primarily from a lesion in the interdigital
cleft.
The primary culture was performed on the farm and further analysis
and PCR in a laboratory of the Finnish Food Authority, Helsinki. The
species detected in the study were: D. nodosus, F. necrophorum, P. levii,
P. melaninogenica, Treponema spp and T. pyogenes. In most of the acute
IP samples (66.7 %), both F. necrophorum and D. nodosus were detected
and a significant association was established between D. nodosus in IP
lesions and high morbidity outbreak in the herd [14]. Therefore, we
tested the effect of F. necrophorum and D. nodosus together, in com-
parison with F. necrophorum without D. nodosus on APPs in samples
from acute IP cows.
2.5. Statistical analysis and models
Data recorded during the herd visits and during the phone inter-
views, the APP values and bacteriological data were collated in Excel
spreadsheets. The statistical analyses were carried out using Stata IC
version 15 (Stata Corporation, Texas, USA).
The study animals were divided into six disease categories: 1)
control cows (IP-free herd), 2) control cows (IP herd), 3) acute IP, 4)
healing IP, 5) DD and 6) other. Possible antimicrobial treatment of the
cows was divided into three categories; 1) no current or previous an-
timicrobial treatment during last month, 2) current antimicrobial
treatment or treatment within 6 days before sampling and 3) previous
treatment with antimicrobials within 7–30 days prior to sampling. The
lactation stage was categorized into three groups: 1–120 DIM, 121–305
DIM and>305 DIM, in which we also included heifers and dry cows.
Moreover, the parity of the cows was categorized into three groups: 1)
heifers and first parity 2) second parity and 3) third or more parity
cows. The breed of the cows was a dichotomous variable, 0) Ayrshire
and 1) Holstein.
Each APP was analyzed separately. The values were described by
means, standard errors and 95 % confidence intervals. A T-test with
unequal variances was performed within various animal groups when
comparing mean APP values of cows in high and moderate morbidity
and control herds, and when comparing mean APP values for acute IP
in F. necrophorum positive cows with or without D. nodosus. A P-
value<0.05 was considered statistically significant.
We studied the association of APPs and various disease categories.
The values of SAA and Hp did not adhere to a normal distribution and
were transformed into a 0 /1 variable. The 90 % values of both groups
of control cows (IP-free herd and IP herd) were used as a reference
value for a healthy animal. The cut-off values were 80 μg/ml for SAA,
and 0.27 g/l for Hp. Logistic mixed models were used to study the as-
sociation of SAA and Hp and various disease categories. The values for
Alb were normally distributed and a regression mixed model was ap-
plied. A possible antimicrobial treatment, DIM, parity and breed were
considered as confounding variables and were kept in all models, and
the herd was included as a random factor. From a total of 203 cows, 198
had a complete dataset and were included in statistical models.
We tested all biologically plausible interactions but detected no
significant association. The models were evaluated by sensitivity and
specificity test and roc-curve of the model. The assumptions of the
model were controlled by normality and scatter plots of the residuals.
2.6. Ethical review
Viikki Campus Research Ethics Committee of Helsinki University
reviewed and approved our research protocol. A written informed
consent to use the animals in our study was obtained from the herd
owners before sampling. After sampling, the farm veterinarian treated
IP and DD cows.
3. Results
3.1. Characteristics of the IP outbreak herds and sampled cows
During the first two months of the IP outbreak, the morbidity was
high (≥50 %) in 7 herds, moderate (9–33%) in 11 herds, and no herd
had an intermediate morbidity. In 6 herds (33.3 %), also cattle less than
2 years old i.e. calves or young heifers had IP cases. In 11/18 herds
(61.1 %), 1–3 cows had to be culled because of IP. The highest culling
rate was 12.2 % (11/90) of the current herd average. Of all producers,
15 (83.3 %) felt that cows were cured well of IP with parenteral anti-
microbial treatment. Approximately one year after the outbreak, 8
herds (44.4 %) still regularly had new sporadic cases of IP.
Several events were reported for the study herds before the IP
outbreaks. All 18 outbreak herds included newly purchased cattle
during the year before the outbreak; 2 herds (11.1 %) included fewer
than five animals, whereas 16 (88.9 %) more. An enlargement of the
barn or construction of a new barn had taken place on 12 farms (66.7
%) in the two years before the outbreak. A change in feeding had oc-
curred within one month before the outbreak on 12 farms (66.7 %).
Eleven producers (61.1 %) reported that feces of the milking cows had
been either too watery or had contained undigested feed particles be-
fore the outbreak. Either one or both of these feeding related problems
had occurred in 16 farms (88.9 %). In the compartment of milking
cows, 2 herds (11.1 %) were overstocked and 6 producers (33.3 %)
reported problems with the cow flow. Additionally, 7 producers (38.9
%) reported at least minor problems in ventilation systems. For 13
outbreak herds (72.2 %), producers were unsatisfied with the cleanli-
ness of the alleys, and for 10 herds (44.4 %) with the cleanliness of the
cows.
The descriptive statistics for the study cows, their clinical signs and
possible antimicrobial treatment is presented in Table 1. At the time of
sampling, 148 (72.9 %) of all sampled cows were not treated with
antimicrobials, 35 (17.2 %) had current, and 20 (9.9 %) previous an-
timicrobial treatment.
3.2. Acute phase response
The increase of SAA and Hp and decrease of Alb was evident in
acute IP cows. Table 2 contains the means, standard errors and 95 %
confidence intervals of APPs in various disease groups.
In the analyses of APPs, the upper limit for reference value for SAA
was 80 μg/ml, and 0.27 g/l for Hp. The probability of SAA and Hp
exceeding the reference value with acute IP cows was apparent
(Table 3). Table 3 presents the results of logistic mixed models of SAA
and Hp, and Table 4 the regression mixed model of Alb. The herd af-
fected values for Hp (P= 0.05) and Alb (P= 0.02).and a trend existed
for SAA (P= 0.06).
3.3. APP values in high and moderate morbidity herds
We compared the APP values in various disease categories among
herds of various morbidity and control herds. The mean values for SAA
and Hp of acute IP were elevated in herds of high morbidity in com-
parison with moderate morbidity herds (P < 0.01). Fig. 1 shows the
mean values and standard errors of APPs in various disease categories
in high morbidity, moderate morbidity and control herds (IP-free
herds).
Furthermore, we compared various APPs of acute IP cows with F.
necrophorum and D. nodosus (n= 31) and F. necrophorum without D.
nodosus (n= 13) in high and moderate morbidity herds (n=44). The
mean value and SE for SAA was 450.7 μg/ml± 59.3 incows with F.
necrophorum and D. nodosus, and 140.2 μg/ml±41.1 in cows with F.
necrophorum without D. nodosus. The mean values for Hp were 2.85 g/
l ± 0.4 and 1.54 g/l ± 0.4, and Alb 36.4 g/l ± 0.6 and 35.7 g/
l ± 0.7, respectively. The values for Alb did not differ between acute IP
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cows from herds of various morbidities. Fig. 2 shows the results for SAA
and Hp in both morbidity categories. Statistical difference existed be-
tween acute IP cows with F. necrophorum and D. nodosus in high
(n=21) and moderate morbidity (n= 10) herds in SAA (P < 0.01)
and in haptoglobin (P < 0.05) values.
4. Discussion
We investigated the association among clinical signs, bacteriological
findings and APPs to evaluate the degree of infection in naturally oc-
curring IP. The study cows with clinical signs of acute IP had clearly
elevated levels of SAA and Hp, and decreased concentrations of Alb, the
negative APP, when compared with clinically healthy control cows. Our
findings show that IP causes a strong APR, which was more evident
than for DD and other hoof diseases included in this study, and other
causes of lameness previously investigated [23–25]. Furthermore, the
APR was more distinguishable in herds with high morbidity of IP (> 50
%) in comparison with herds of moderate morbidity (9–33%). This
could indicate presence of a more virulent agent in high morbidity
herds, a higher infection pressure or a weaker immunity. Moreover, the
acute IP cows with both F. necrophorum and D. nodosus had more ele-
vated concentrations of SAA and Hp than acute IP cows with F. necro-
phorum without D. nodosus, and the values were further increased in
cows of high morbidity herds. In our earlier study, we demonstrated
that in most of the acute IP samples, both F. necrophorum and D. nodosus
were detected and a significant association was established between D.
nodosus in IP lesions and a high morbidity outbreak in the herd [14].
Thus, our new findings for APR in IP support our hypothesis of D. no-
dosus affecting the severity of IP. Previously, D. nodosus was detected in
healthy hooves [34] and was associated with ID [34] and DD [34–36].
Rasmussen et al. [37] speculated that D. nodosus could break down the
epidermal barrier, creating a suitable environment for secondary in-
vaders. F. necrophorum is regarded as being the major pathogen in IP
[12–14]. However, there remain difficulties in establishing absolute
clarity for the role of other bacteria than F. necrophorum in the patho-
genesis of IP and further studies on IP bacteriology and on virulence of
both F. necrophorum and D. nodosus are merited.
The values for SAA and Hp were considerably increased in the acute
stage of IP. This was expected because SAA and Hp are major APPs in
cattle [19,21]. The current understanding is that SAA is the first line
and Hp the second line APP; first line APPs are primarily induced by IL-
1 type cytokines whereas second line APPs are induced by IL-6 type
[18,20]. Because we do not know the exact date of the IP onset at the
time of sampling, our cases of IP, especially the group of healing IP, can
be somewhat divergent. This may be the reason why we observed only a
trend (p=0.06) among Hp values in our group of healing IP cows i.e.
during the later stage of IP. Horadagoda et al. [38] postulated that an
increase in both SAA and Hp in comparison with an increase solely in
SAA could indicate that a greater inflammatory reaction has occurred.
Alb is a major plasma protein, featuring the plasma colloidal os-
motic pressure and being associated with the balance of body fluids
[39,40]. Hypoalbuminemia is detected in several pathologic processes
or in physiological conditions [40]. During APR, synthesis of Alb is
probably down-regulated and amino acids are used for the synthesis of
the positive APPs [18]. In our study cows, the values of Alb were de-
creased in acute IP, but they were also affected by DIM and parity. Also
feeding is known to influence the blood albumin levels in cattle
[41,42]. Thus, albumin alone cannot be regarded as a useful marker of
infection in a single cow.
Our previous survey detected animal purchase and enlargement of
Table 1
Descriptive data for the sampled cows (N=203); affected foot, clinical signs and possible antimicrobial treatment prior to sampling in various disease groups¹.
Number of animals and the percentage in each group is presented.
Variable Control (IP free herd) Control (IP herd) Acute IP Healing IP DD Other
Cow 19 (9.4%) 42 (20.7%) 60 (29.6%) 34 (16.7%) 14 (6.9%) 34(16.7%)
Front feet² 0 (0%) 5 (2.5%) 11 (5.4%) 3 (1.5%) 1 (0.5%) 3 (1.5%)
Hind feet² 19 (9.3%) 37 (18.2%) 49 (24.1%) 31 (15.3%) 13(6.4%) 31 (15.3%)
Clinical signs
Lameness 0/19 (0%) 0/42 (0%) 36/53(689%) ³ 16/29 (55.2%) ³ 3/13 (23.1%) ³ 8/32 (25.0%) ³
Swelling 0/19 (0%) 0/42 (0%) 57/59 (96.5%) ³ 31/34 (91.2%) 4/14 (28.6%) 13/33 (39.4%) ³
Odor 0/19 (0%) 0/42(0%) 8/43 (18.6%) ³ 0/26 (0%) ³ 4/9 (44.4%) ³ 0/27 (0%) ³
Antimicrobial treatment
None 19/19 (100%) 42/42 (100%) 35/60 (58.3%) 6/34 (17.7%) 12/14 (85.8%) 34/34 (100%)
Current 0/19 (0%) 0/42 (0%) 19/60 (31.7%) 15/34 (44.1%) 1/16 (7.1%) 0/34 (0%)
Previous 0/19 (0%) 0/42 (0%) 6/60 (10.0%) 13/34 (38.2%) 1/16 (7.1%) 0/34 (0%)
¹ Control cows with no outbreak of interdigital phlegmon (IP-free herd), control cows in herds with an outbreak of interdigital phlegmon (IP herd, acute IP, healing
stage of IP, digital dermatitis (DD) and other hoof diseases (Other). In a group of other hoof diseases were cases of interdigital dermatitis, sole ulcer, and white line
abscess. IP= interdigital phlegmon.
² Percentage of all sampled feet.
³ Missing data for some sampled cows.
Table 2
The number of cows, means, standard errors and 95 % confidence intervals for
serum amyloid A, haptoglobin and albumin in blood samples from cows in the
various disease groups¹.
n Mean SE 95% CI
Serum amyloid A (μg/ml)
Control (IP-free herd) 19 52.59 16.49 20.08–85.10
Control (IP herd) 42 33.00 6.13 20.83–45.02
Acute IP 60 308.05 38.65 231.83–384.27
Healing IP 34 74.12 18.50 37.65–110.60
DD 14 90.91 40.70 10.66–171.15
Other 34 89.33 19.40 51.07–127.59
Haptoglobin (g/l)
Control (IP-free herd) 19 0.23 0.07 0.08–0.37
Control (IP herd) 42 0.16 0.03 0.11–0.21
Acute IP 60 2.15 0.25 1.66–2.64
Healing IP 34 0.50 0.13 0.25–0.76
DD 14 0.17 0.29 0.11–0.23
Other 34 0.55 0.15 0.24–0.87
Albumin (g/l)
Control (IP-free herd) 19 39.54 0.58 38.39–40.69
Control (IP herd) 42 37.79 0.38 37.04–38.55
Acute IP 60 35.91 0.36 35.20–36.62
Healing IP 34 36.76 0.44 35.90–37.63
DD 14 37.70 0.59 36.53–38.86
Other 34 37.50 0.39 36.72–38.28
n = number of cows, SE= standard error; 95 % CI= 95 % confidence interval;
IP= interdigital phlegmon.
¹ Control cows with no outbreak of interdigital phlegmon (IP-free herd),
control cows in herds with an outbreak of IP (IP herd), IP in acute stage (acute
IP) and healing stage (healing IP), digital dermatitis (DD) and other hoof dis-
eases (other).
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the barn as risk factors for an outbreak of IP to occur [43]. Similarly,
every outbreak herd in the current study included newly purchased
animals within one year before the outbreak, and 12 (66.7 %) herds had
undergone an enlargement or construction of the barn during the two
years before the outbreak. Interestingly, in this study, feeding-related
problems for several IP herds (88.9 %) were reported just prior to the
outbreak. Because of the low number of herds in this study, risk factors
could not be investigated, and further research should be performed to
confirm this speculation.
Previous research on APR on hoof diseases has typically included
various diagnoses in the same study. Kujala et al. [23] reported elevated
SAA concentrations in 16 dairy cattle with either sole ulcer, white line
disease or both, but did not detect any variation in Hp values between
lame and control groups. Tóthová et al. [26] had a group of 35 lame
heifers with various causes of lameness and was able to detect a dif-
ference between lame and non-lame groups in SAA and Hp, but not in
Alb. Tadich et al. [24] studied lame dairy cows and revealed elevated
concentrations of Hp for all levels of lameness (locomotion score> 1),
when locomotion was scored on a scale of 1– 5. O´Driscoll et al. [25]
investigated differences in metabolite status of dairy cows with or
without sole ulcer and detected higher Hp levels for lame cows.
Earlier studies of infectious hoof diseases and APR are scant. A study
of Smith et al. [27] included 7 IP cases, all with elevated Hp con-
centrations compared with controls. An Iranian study [28] measured
Hp and SAA in a lameness group, a F. necrophorum-positive lameness
group and a healthy group, and established a significant difference for
values of both lameness groups when compared with controls. The cows
were diagnosed as ID in the study, but the description of the signs of the
affected cows in the article resembles that of IP as described by Gupta
et al. [8]. The nomenclature of infectious hoof diseases has varied and
therefore, interpretation of older results is occasionally difficult. Tó-
thová et al. [29] detected significantly lower Alb values in 23 dairy
cows with hoof diseases than in controls. In their study hoof diseases
included cases of DD, pododermatitis, laminitis and sole ulcer.
Our study design depended on occurrence of IP outbreaks. Due to
long distances between farms in Finland, it was occasionally difficult to
reach a farm on time and get enough samples from cows during the
early acute stage of IP and which had not yet been treated with
Table 3
The final logistic mixed models for serum amyloid A to elevate over 80 μg/ml and haptoglobin to elevate over 0.27 g/l with cow-level factors and herd as a random
factor¹ (N= 198).
Serum amyloid A Haptoglobin
OR P-value 95% CI. Wald OR P-value 95% CI. Wald
Disease category < 0.01 < 0.01
Control (IP herd) 1 1
Control (IP-free herd) 1.63 0.63 0.23–11.76 0.86 0.89 0.09–7.61
Acute IP 38.16 < 0.01 9.08–160.37 37.93 <0.01 8.98–160.29
Healing IP 2.59 0.31 0.41–16.16 4.96 0.08 0.83–29.51
DD 6.42 0.05 0.98–42.08 2.83 0.29 0.41–19.54
Other 3.48 0.09 0.84–14.38 3.58 0.08 0.86–14.82
Antimicrobial treatment 0.24 0.19
None 1 1
Current 1.29 0.71 0.34–4.84 2.62 0.18 0.64–10.61
Previous 0.26 0.16 0.04–1.68 0.71 0.69 0.13–3.87
DIM 0.17 0.14
1–120 1 1
121–305 0.41 0.06 0.16–1.05 0.37 0.05 0.14–0.99
> 305 0.55 0.27 0.19–1.59 0.65 0.43 0.23–1.87
Parity 0.29 0.37
≤1st 1 1
2nd 1.06 0.91 0.37–3.04 0.80 0.68 0.27–2.33
≥3rd 2.12 0.13 0.80–5.64 1.76 0.25 0.68–4.65
Breed
Ayrshire 1 1
Holstein 0.43 0.06 0.17–1.04 0.70 0.44 0.05–1.71
Constant 0.42 0.31 0.08–2.27 0.27 0.13 0.05–1.47
IP= interdigital phlegmon; OR=odds ratio; 95 % CI=95 % confidence interval; Wald=Wald-test was used to test the overall P-value of the variable.
¹ The disease categories were control cows with an outbreak of interdigital phlegmon (IP herd), control cows in herds with no outbreak of IP (IP free herd), IP in
acute stage (acute IP), and healing stage (healing IP), digital dermatitis (DD) and other hoof diseases (Other). In a group of other hoof diseases were cases of
interdigital dermatitis, sole ulcer, and white line abscess.
Table 4
The final regression mixed model for albumin in various disease categories with
cow-level factors and herd as a random factor ¹ (N= 198).
Coefficient P-value 95% CI Wald
Disease category < 0.01
Control (IP herd) 1
Control (IP-free herd) 1.23 0.12 −0.30 to 2.77
Acute IP −1.85 <0.01 −2.90 to -0.81
Healing IP −0.92 0.20 −2.31 to 0.47
DD −0.76 0.34 −2.32 to 0.79
Other −0.82 0.14 −1.68 to 0.52
Antimicrobial treatment 0.53
None 1
Current −0.60 0.30 −1.68 to 0.52
Previous −0.06 0.94 −1.51 to 1.39
DIM <0.01
1–120 1
121–305 1.62 <0.01 0.99 to 2.34
> 305 1.66 <0.01 0.76 to 2.55
Parity 0.04
≤1st 1
2nd 0.76 0.07 −0.05 to 1.58
≥3rd 0.90 0.03 0.11 to 1.68
Breed
Ayrshire 1
Holstein 0.51 0.16 −0.20 to 1.21
Constant 35.88 <0.01 34.57 to 37.20
IP= interdigital phlegmon; 95 % CI=95 % confidence interval; Wald=Wald-
test was used to test the overall P-value of the variable.
¹ The disease categories were control cows with an outbreak of interdigital
phlegmon (IP herd), control cows in herds with no outbreak of IP (IP-free herd),
IP in acute stage (acute IP), and healing stage (healing IP), digital dermatitis
(DD) and other hoof diseases (Other). In a group of other hoof diseases were
cases of interdigital dermatitis, sole ulcer, and white line abscess.
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antimicrobials. Considering the severe clinical signs of the cows, the
treatment was not delayed for study purposes. However, in both high
and moderate morbidity herds we were able to collect almost the same
number of samples from acute IP cows. In each herd, we only examined
and sampled cows on a single day and thus we did not follow up the
healing process of an individual cow. The diagnosing was based on
clinical signs only and was occasionally challenging. Even though the
cows were categorized as IP or DD cows, in some cases also other hoof
diseases may have been present. The control cows were chosen among
clinically healthy cows in each herd. However, it is possible some of
these cows might have experienced a subclinical disease at the time of
sampling.
These results suggest that SAA and Hp could be used in the de-
termination of the severity of IP infection and to a certain extent they
can add information on predicting the possible outcome of the disease.
Furthermore, these results should be borne in mind when deciding on
the treatment of a cow suffering from IP. Considering the strong APR, IP
cows should be treated as quickly as possible and an appropriate an-
algesic should be administered in addition to antimicrobials.
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Fig. 1. The mean values and standard errors for A) serum amyloid A, B) hap-
toglobin and C) albumin in various disease categories in high and moderate
morbidity outbreak herds and control herds. The disease categories were con-
trol cows, acute interdigital phlegmon (Acute IP), healing stage of IP (healing
IP), digital dermatitis (DD) and a group of other hoof diseases (Other) that
included cases of ID, sole ulcer and white line abscess. The number of sampled
animals (n) in each group is presented under the columns of albumin values.
Statistical difference is indicated with * (P < 0.01).
Fig. 2. The concentrations of A) serum amyloid A and B) haptoglobin in high
and moderate morbidity herds of cows suffering from acute interdigital
phlegmon with Fusobacterium necrophorum (Fn) and with F. necrophorum and
Dichelobacter nodosus (FnDn) The number of sampled animals in each group is
presented under the columns of haptoglobin values. In box and whiskers plots,
the median is represented as a line that divides the box into two parts. The box
represents the mid 50 % of the values while the whiskers scores outside the mid
50 %. Statistical difference existed between FnDn cows in high and moderate
morbidity herds in SAA (P < 0.01) and in haptoglobin (P < 0.05) values.
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